Edition

Lynn Morris

0

Comments

Medical Scientist at the National Institute for Communicable Diseases; Research Associate at CAPRISA; Research Professor in the School of Pathology, University of the Witwatersrand

Shutterstock

November 30, 2017

Designer proteins: the new generation of HIV vaccines being put to the test

Penny Moore, University of the Witwatersrand and Lynn Morris, University of the Witwatersrand

Three new HIV vaccine concepts which rely on high-tech designer proteins are being trialled to see if they can stop the virus.

A women gets an HIV test. Sub-Saharan Africa accounts for the majority of the HIV deaths annually. World Bank Collection/flickr

November 29, 2015

Two trials signal pivotal point in fight against the AIDS epidemic

Lynn Morris, University of the Witwatersrand; Nono Mkhize, National Institute for Communicable Diseases; Penny Moore, University of the Witwatersrand, and Zanele Ditse, National Institute for Communicable Diseases

Two major clinical trials will be conducted in South Africa in 2016 to test ways of preventing new HIV infections.

Contact Lynn for

General
Media request
Speaking request
Consulting / Advising
Research collaboration
Research supervision

Article Feed
Joined August 13, 2015